| Literature DB >> 35756064 |
Haoran Zhong1,2, Yamei Jin1,2.
Abstract
Schistosomiasis is a parasitic disease that is caused by helminths of the genus Schistosoma. The dioecious schistosomes mate and lay eggs after undergoing a complex life cycle. Schistosome eggs are mostly responsible for the transmission of schistosomiasis and chronic fibrotic disease induced by egg antigens is the main cause of the high mortality rate. Currently, chemotherapy with praziquantel (PZQ) is the only effective treatment against schistosomiasis, although the potential of drug resistance remains a concern. Hence, there is an urgent demand for new and effective strategies to combat schistosomiasis, which is the second most prevalent parasitic disease after malaria. MicroRNAs (miRNAs) are small non-coding RNAs that play pivotal regulatory roles in many organisms, including the development and sexual maturation of schistosomes. Thus, miRNAs are potential targets for treatment of schistosomiasis. Moreover, miRNAs can serve as multifunctional "nano-tools" for cross-species delivery in order to regulate host-parasite interactions. In this review, the multifunctional roles of miRNAs in the growth and development of schistosomes are discussed. The various regulatory functions of host-derived and worm-derived miRNAs on the progression of schistosomiasis are also thoroughly addressed, especially the promotional and inhibitory effects on schistosome-induced liver fibrosis. Additionally, the potential of miRNAs as biomarkers for the diagnosis and treatment of schistosomiasis is considered.Entities:
Keywords: MicroRNA; biomarker; development; diagnosis; liver fibrosis; schistosomiasis
Year: 2022 PMID: 35756064 PMCID: PMC9218868 DOI: 10.3389/fmicb.2022.925386
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Summary of miRNAs upregulated in the different developmental stages or sexes of schistosome.
| Species | Life stages or gender | miR-name | References |
|
| Egg | sja-miR-1, sja-miR-36-3p, sja-miR-71, sja-miR-71b-5p, sja-miR-124-3p |
|
| Cercaria | sja-let-7, sja-bantam, sja-miR-1, sja-miR-2a-3p, sja-miR-2a-5p, sja-miR-2b-3p, sja-miR-2b-5p, sja-miR-7-3p, sja-miR-7-5p, sja-miR-8-3p, sja-miR-10-5p, sja-miR-31-5p, sja-miR-36-3p, sja-miR-36-5p, sja-miR-71, sja-miR-71b-3p, sja-miR-71b-5p, sja-miR-124-3p, sja-miR-125b, sja-miR-133, sja-miR-190-5p, sja-miR-219-5p, sja-miR-3479-3p, sja-miR-3479-5p, sja-miR-3485-3p, sja-miR-3487, sja-miR-3489, sja-miR-3490, sja-miR-3491, sja-miR-3492, sja-miR-3493, sja-miR-3496, sja-miR-3497, sja-miR-3499, sja-miR-3500, sja-miR-3501, sja-miR-3502, sja-miR-3503, sja-miR-3504 | ||
| Lung-stage schistosomula | sja-let-7, sja-miR-2c-3p, sja-miR-2c-5p, sja-miR-2d-3p, sja-miR-2d-5p, sja-miR-2e-3p, sja-miR-2e-5p, sja-miR-10-3p, sja-miR-61, sja-miR-124-5p, sja-miR-190-3p, sja-miR-2162-3p, sja-miR-2162-5p, sja-miR-3488, sja-miR-3494, sja-miR-3495, sja-miR-3498, sja-miR-3506 |
| |
| 16-day MM | sja-miR-2b, sja-miR-2d, sja-miR-2e, sja-miR-7, sja-miR-8, sja-miR-61, sja-miR-124, sja-miR-219, sja-miR-227, sja-miR-277b, sja-miR-2162, sja-miR-3479, sja-miR-3488 |
| |
| 16-day MF | sja-miR-31 |
| |
| 22-day MM | sja-miR-2b, sja-miR-2d, sja-miR-2e, sja-miR-7, sja-miR-8, sja-miR-61, sja-miR-124, sja-miR-219, sja-miR-227, sja-miR-277b, sja-miR-2162, sja-miR-3479, sja-miR-3488 |
| |
| 22-day MF | sja-bantam, sja-miR-2c, sja-miR-31, sja-miR-1989 |
| |
| 23-day SF | sja-miR-1, sja-miR-7, sja-miR-7-5p, sja-miR-71 |
| |
| 25-day MF | sja-bantam, sja-miR-219-3p, sja-miR-3485-5p, sja-miR-3486-5p, sja-miR-3488, sja-miR-3489, sja-miR-3490, sja-miR-3491, sja-miR-3493, sja-miR-3494, sja-miR-3495, sja-miR-3497, sja-miR-3498, sja-miR-3500, sja-miR-3501, sja-miR-3502, sja-miR-3504, sja-miR-3505, sja-miR-3506, sja-miR-3507 |
| |
| 25-day SF | sja-let-7, sja-miR-1, sja-miR-2c-5p, sja-miR-7-5p, sja-miR-8-3p, sja-miR-10-5p, sja-miR-36-3p, sja-miR-36-5p, sja-miR-124-3p, sja-miR-124-5p, sja-miR-125a, sja-miR-133, sja-miR-3479-5p, sja-miR-3482-3p, sja-miR-3482-5p, sja-miR-3503 |
| |
| 28-day MM | sja-miR-7, sja-miR-8, sja-miR-61, sja-miR-124, sja-miR-219, sja-miR-227, sja-miR-2162, sja-miR-3479, sja-miR-3488 |
| |
| 28-day MF | sja-bantam, sja-miR-2c, sja-miR-31, sja-miR-1989 |
| |
| 49-day MM | sja-let-7, sja-miR-1, sja-miR-2a-3p, sja-miR-2e-3p, sja-miR-2e-5p, sja-miR-7-5p, sja-miR-8-3p, sja-miR-10-3p, sja-miR-10-5p, sja-miR-61, sja-miR-71, sja-miR-124-3p, sja-miR-125a, sja-miR-125b, sja-miR-133, sja-miR-190-5p, sja-miR-219-3p, sja-miR-219-5p, sja-miR-227, sja-miR-307, sja-miR-2162-3p, sja-miR-3479-3p, sja-miR-3480-5p, sja-miR-3482-3p, sja-miR-3496,sja-miR-3503 |
| |
| 49-day MF | sja-bantam, sja-miR-2c-3p, sja-miR-2c-5p, sja-miR-2d-3p, sja-miR-36-3p, sja-miR-71b-5p, sja-miR-2162-5p, sja-miR-3479-5p, sja-miR-3487, sja-miR-3488, sja-miR-3489, sja-miR-3491, sja-miR-3492, sja-miR-3493, sja-miR-3494, sja-miR-3495, sja-miR-3498, sja-miR-3499, sja-miR-3505, sja-miR-3506, sja-miR-3507 |
| |
|
| Lung-stage schistosomula | sma-bantam, sma-miR-71 |
|
| 49-day MM | sma-miR-1, sma-miR-61, sma-miR-281 |
| |
| 49-day MF | sma-bantam, sma-miR-2c, sma-miR-2d, sma-miR-2f, sma-miR-31, sma-miR-36b, sma-miR-71b, sma-miR-755, sma-miR-8437, sma-miR-8447 |
| |
| 50-day adult worm pair | sma-miR-92a, sma-miR-125, sma-miR-250, sma-miR-new-5-5p |
| |
|
| 90-day MM | sha-let-7, sha-miR-1, sha-miR-7a, sha-miR-745 |
|
| 90-day MF | sha-bantam, sha-miR-71a, sha-miR-71b, sha-miR-125b, sha-miR-2162 |
|
SF, single-sex infected female; MF, mated female; MM, mated male.
FIGURE 1Development of the immune response and representative differentially expressed host miRNAs during Schistosoma japonicum infection. In the early stage of infection, the host produces a T helper type 1 (Th1) response against the migrating immature schistosomula (about 15 days after infection). After the mated worms lay eggs (about 24 days after infection), which further secrete antigens that stimulate the body to generate a strong Th2 response. Ultimately, when the disease develops into the chronic liver fibrosis, the Th2 response is diminished but still dominant. During infection, mmu-miR-223, mmu-miR-146b, and mmu-miR-155 in the liver tissues continuously elevated at 15, 30, 45 days after infection (Cai et al., 2013b). d, days. This figure was created with Biorender.com.
FIGURE 2MiRNAs regulate schistosome-induced liver fibrosis through TGF-β/SMAD signaling pathway. The adult paired worms migrate to the portal vein and lay eggs. TGF-β/SMAD signaling pathway, one of the most critical signaling pathways that associated with liver fibrosis in hepatic stellate cells, can be activated by soluble egg antigen TGF-β/SMAD signaling pathway. TGF-β binds to the receptors (TβRI, TβRII, TβRIII) leading to phosphorylation of Smad-2 and Smad-3, followed by aggregation with Smad-4 and subsequently drives the expression of Smad-7 which negatively regulates TGF-β/SMAD signaling pathway. Both host-derived miRNAs (let-7b, miR-130-3p, miR-200a, miR-21, miR-96, miR-454, and miR-351) and worm-derived miRNAs secreted from egg-derived extracellular vesicles (sja-miR-71a and sja-miR-2162) exert vital roles in the progression of schistosome-induced liver fibrosis. This figure was created with Biorender.com.
Summary of miRNAs involved in the pathogenesis of schistosomiasis.
| MiR-name | Target genes | Pathways | Function | References |
| Let-7b | TβRI | TGF-β/SMAD signaling pathway | Anti-fibrosis |
|
| MiR-21 | SMAD7 | TGF-β/SMAD and IL-13/STAT6 signaling pathways | Pro-fibrosis |
|
| MiR-27b | PPARγ | TGF-β signaling pathway | Pro-fibrosis |
|
| MiR-92a-2-5p | TLR2 | Unstudied | Anti-fibrosis |
|
| MiR-96 | SMAD7 | TGF-β/SMAD signaling pathway | Pro-fibrosis |
|
| MiR-130a-3p | MAPK1, TβRI, TβRII | TGF-β and MAPK signaling pathways | Anti-fibrosis |
|
| MiR-146a/b | STAT1 | IFN-γ signaling pathway | Macrophage transformation |
|
| MiR-155 | FOXO3a | ERK1 signaling pathway | Pro-fibrosis |
|
| MiR-181a | TLR4 | TLR4 receptor signaling pathway | Anti-fibrosis |
|
| MiR-182 | FOXO1 | PI3K/AKT signaling pathway | Pro-fibrosis |
|
| MiR-200a | TGF-β2 | TGF-β signaling pathway | Anti-fibrosis |
|
| MiR-203-3p | SMAD3 | SMAD signaling pathway | Anti-fibrosis |
|
| MiR-351 | VDR | SMAD and IFN-γ signaling pathways | Pro-fibrosis |
|
| MiR-454 | SMAD4 | SMAD signaling pathway | Anti-fibrosis |
|
| Sja-miR-1 | SFRP1 | Wnt/β-catenin pathway | Pro-fibrosis |
|
| Sja-miR-71a | SEMA4D, FZD4 | TGF-β/SMAD and IL-13/STAT6 signaling pathways | Anti-fibrosis | |
| Sja-miR-125b, Sja-bantam | PROS1, FAM212B, CLMP | Unstudied | Macrophage proliferation |
|
| Sja-miR-2162 | TβRIII | TGF-β/SMAD signaling pathway | Pro-inflammatory, Pro-fibrosis |
|
| Sja-miR-3096 | PIK3C2A | Unstudied | Tumor suppressor |
|